A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD
A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD have?
A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD has 53 citations in the OpenAlex counts ScholarIQ stores.
When was A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD published?
A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD has 2023 year in the ScholarIQ index.
What is the open-access status of A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD?
A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD has gold oa status in the ScholarIQ index.
What is the DOI of A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD?
The DOI for A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD is on the source record.
What is the PMID of A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD?
The PMID for A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD is on the source record.
What is the OpenAlex record for A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD?
The OpenAlex for A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD is on the source record.